Johnson & Johnson

Johnson & Johnson ordered to pay $1.04 bn over faulty hip implants

02 Dec 2016

In lawsuits that were combined in a trial, the federal jury concluding that J&J misled patients and their doctors about the safety of the Pinnacle hip implant

Swiss biotech company Actelion rejects complete takeover by Johnson & Johnson

01 Dec 2016

Johnson & Johnson in talks to buy Swiss biotechnology firm Actelion

25 Nov 2016

J&J loses third lawsuit over talcum powder link to ovarian cancer

29 Oct 2016

Johnson & Johnson, which is facing over 1,700 lawsuits in state and federal courts over ignoring studies linking its baby powder and Shower-to-Shower talc products to ovarian cancer, has been asked to pay a California woman more than $70 million in damages

J&J warns of hack flaw in insulin pump, calls risk ‘extremely low’

06 Oct 2016

Johnson & Johnson is warning patients that it has learned of a security vulnerability in one of its insulin pumps that a hacker could exploit to overdose diabetic patients with insulin

Another woman files case against Johnson & Johnson talc

27 Sep 2016

Abbott Laboratories to sell eye care business to Johnson & Johnson for $4.325 bn

17 Sep 2016

J&J loses rheumatic drug patent battle; boost for Pfizer

18 Aug 2016

Johnson & Johnson to buy hair-care company Vogue International for $3.3 bn

02 Jun 2016

J&J to acquire dermocosmetics products maker NeoStrata

27 Apr 2016

Maharashtra FDA to test J&J talcum powder for carcinogens

12 Mar 2016

J&J must pay $72 mn damages in talc case

25 Feb 2016

Johnson & Johnson to cut 3,000 jobs in its medical devices unit

20 Jan 2016

J&J launches clinical trial of preventive Ebola vaccine regimen

09 Oct 2015

FBI probes role of J&J's hysterectomy device in spreading cancer

30 May 2015

ITC to acquire J&J's Savlon, Shower to Shower brands in India

13 Feb 2015

Johnson & Johnson explores sale of artificial sweetener brand Splenda

04 Dec 2014

J&J Pte acquires ORSLTM ready-to-drink electrolyte brand from Jagdale Industries

08 Nov 2014

J&J accepts $4 bn bid from Carlyle for its ortho-clinical diagnostics business

01 Apr 2014

Johnson & Johnson's  ortho-clinical diagnostics unit was created in 1994 when it acquired the clinical diagnostics division of Eastman Kodak and formed Johnson & Johnson Clinical Diagnostics, which was then merged in 1997 with Ortho Diagnostic Systems

J&J to sell Ortho Clinical Diagnostics unit to Carlyle for $4.15 bn

17 Jan 2014

US healthcare major Johnson & Johnson (J&J) yesterday agreed to sell its Ortho Clinical Diagnostics (OCD) unit to private equity firm Carlyle Group for $4.15 billion.

Danaher, Blackstone Group jointly bid for Johnson & Johnson's diagnostics unit

08 Nov 2013

Mis-selling of drugs to cost J&J $2.2 bn in US settlement

05 Nov 2013

The cases, which date from the late 1990s through the early 2000s, involve alleged kickbacks to doctors and pharmacies to promote the antipsychotic drugs Risperdal and Invega, and heart drug Natrecor

PE firms in race for J&J’s Ortho Clinical Diagnostics unit

01 Oct 2013

Private equity firms have tabled preliminary bids for Johnson & Johnson's Ortho Clinical Diagnostics unit, which could fetch the US healthcare major around $5 billion

J&J launches sale of Ortho Clinical Diagnostics unit

07 Sep 2013

J&J to buy Aragon Pharmaceuticals; deal potential $1 bn

17 Jun 2013